SLC3A2 and cancer: Additionally, immunotherapy activated CD8+ T cells can induce ferroptosis in cancer cells by interferon gamma-mediated downregulation of the two subunits of system Xc−, solute carrier family 7 member 11 (SLC7A11) and SLC3A2, leading to a decrease in the antioxidant capacity of cancer cells [16].